Evernorth Therapeutic Resource Center Plus℠ is a premium offering now available to plan sponsors navigating select high-spend specialty conditions like hemophilia. Hemophilia is a genetic, incurable bleeding disorder affecting 30,000 males in the United States. The care journey for and costs associated with hemophilia are often unpredictable, complex, and expensive for plans and patients. 

Evernorth Therapeutic Resource Center Plus℠ is a premium offering now available to plan sponsors navigating select high-spend specialty conditions like hereditary angioedema (HAE). HAE is a rare, often hereditary swelling condition that affects 6,000 patients in the U.S. Due to many variables, HAE can be unpredictable for plan sponsors, making it difficult to budget costs and ensure patients are on the right combination of treatments. 

Evernorth Therapeutic Resource Center Plus℠ (TRC) is a premium offering now available to plan sponsors navigating select high-spend specialty conditions like hemophilia and hereditary angioedema (HAE). The offering leverages the power of our proven TRC model and connected management strategies to achieve more benefit predictability and lower costs.